Medical device company addressing heat-related fatalities ColdVentures announced on Friday that it has partnered with Medco Sports Medicine, a provider of sports medicine supplies, to distribute its ColdVest technology.
This collaboration aims to equip athletic trainers, educators and sports medicine professionals with an essential tool to prevent and treat heat stroke in athletes and students.
ColdVest, an FDA Class 1 medical device, rapidly reduces core body temperature using patented endothermic cooling technology. Activation requires only liquid, eliminating the need for electricity, ice, or refrigeration, making it lightweight, portable, and practical for high-risk environments.
Medco Sports Medicine, with over six decades of industry trust, will serve as the exclusive distributor of ColdVest in the sports medicine market. This agreement ensures ColdVest's availability to safeguard athletes and students during training, competitions and events. By stabilizing individuals suffering from heat-related illnesses within minutes, ColdVest offers critical support until emergency medical services arrive.
DATROWAY receives US priority review for first-line metastatic triple negative breast cancer
Lupin launches Dasatinib tablets in US market
Natera submits Signatera CDx PMA to FDA for bladder cancer use
Pharming receives FDA complete response letter for paediatric Joenja application
Trace Biosciences' IND application for nerve-specific imaging agent approved by FDA
Frontage expands early phase clinical research capabilities across US and China
MicuRx Pharmaceuticals' IND application for MRX-5 cleared by FDA
FDA approves Tenpoint Therapeutics' YUVEZZI as first dual-agent eye drop for presbyopia
Summit Therapeutics' BLA for ivonescimab in EGFR-mutated NSCLC accepted by FDA
WuXi Biologics collaborates with Sinorda Biomedicine for antibody development
Biogen's litifilimab receives FDA Breakthrough Therapy Designation for CLE
Glaukos receives FDA approval for repeat administration of iDose TR
Guerbet's contrast agent Elucirem approved by European Commission in children from birth
Spine Innovation's LOGIC Titanium Implant System receives US FDA 510(k) market approval